Search the Newsreel

Sanara MedTech Q2 Results: Sales Rise 9% YoY, EPS Misses Estimate

Sanara Medtech earnings missed by $0.02, revenue fell short of estimates

Sanara MedTech (SMTI) grows H1 2026 revenue to $55.9M and trims loss

Sanara MedTech Inc. (SMTI) reported significant revenue growth for the first half of 2026, reaching $55.9 million, primarily driven by strong sales of its soft tissue repair products. The company also substantially reduced its net loss attributable to shareholders, nearly breaking even with a …

Sanara MedTech Inc. Q2 2026: Revenue $28.14M, EPS $(0.05) — 10-Q Summary

Sanara MedTech Inc. reported its Q2 2026 financial results, with revenue reaching $28.14M, a 9.1% increase year-over-year. The company posted a diluted loss per share of $(0.05), an improvement from $(0.23) in Q2 2025. This growth was primarily driven by surgical soft tissue repair …

Medtronic PLC stock outperforms competitors on strong trading day

Medtronic PLC (MDT) stock rallied 1.42% to $90.68 on Tuesday, outperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average both saw declines. This marks the third consecutive day of gains for Medtronic's stock.

Sanara MedTech Inc. (SMTI) Releases Q2 2026 Earnings: Revenue Rises 8.9%

Sanara MedTech Inc. (SMTI) reported an 8.9% increase in revenue for Q2 2026, reaching $28.1 million, with gross profit rising to $26.2 million. Despite strong top-line growth, the company posted a net loss of $(0.05) per diluted share. The article also details hedge fund …

Sanara MedTech (SMTI) grows revenue, posts Q2 loss amid pending MIMEDX deal

Form 8K Sanara Medtech Inc For: 11 August By Investing.com

This article reports on the filing of a Form 8K by Sanara Medtech Inc. on August 11, 2026. The brief announcement from Investing.com indicates this as a significant event for shareholders and market watchers of SMTI.

MIMEDX Expected to Acquire Sanara MedTech, Pending Closing Conditions

Sanara MedTech reported a 9% increase in Q2 2026 net revenue to $28.1 million and a 14% rise for the first six months to $55.9 million, maintaining a 93% gross margin. The company also announced a signed agreement for its acquisition by MIMEDX, pending …

Medtronic (MDT) Wins Analyst Upgrades, Is It Fully Priced?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic (MDT) has moved back into focus after multiple analyst upgrades tied to what they describe as the company's strongest annual revenue growth …

Did UBS’s Medtronic (MDT) Upgrade, After Strong Cardiac-Led Growth, Just Shift Its Investment Narrative?

MicroPort CardioFlow Signals Revenue Surge as CRM Acquisition Fuels Global Growth

RedTape discusses Q1FY27 results in Aug 11 investor meet

24,967 Shares in Medtronic PLC $MDT Acquired by First Bank & Trust

First Bank & Trust recently acquired 24,967 shares of Medtronic PLC (NYSE: MDT), valued at approximately $1.95 million. This purchase is part of a trend of institutional investment, as 82.06% of Medtronic's stock is held by institutional investors. Analysts generally maintain a "Moderate Buy" …

Earnings call transcript: REDTAPE posts record q1 2026 profit as stock slips

REDTAPE: Q1 FY27 saw record PAT, margin discipline, retail growth, and strategic brand expansion

RedTape Q1 FY27 slides: margin expansion drives record profit

Medtronic (MDT) Stock Looks Fairly Valued On Cash Flow But Cheap On Earnings

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

In the latest close session, Medtronic (MDT) was up +2.58% at $89.41. The stock outperformed the S&P 500, which registered a daily loss of 0.06%. Elsewhere, the Dow lost 0.11%, while the tech-heavy Nasdaq lost 0.32%. The medical device company's stock has climbed by …

REDTAPE: Q1 FY27 saw 3.7% revenue growth, margin expansion, and strategic brand portfolio moves

Redtape net profit rises 13% in Q1FY26 as EBITDA margin doubles

PW Medtech warns of sharp profit drop on infusion set price cuts

Medtronic (MDT) On New CE Mark Win And A Modest Undervalued View

Medtronic (MDT) recently received an expanded CE Mark for its Affera Mapping and Ablation System with Sphere-9 Catheter, leading to a recent positive share price momentum despite longer-term declines. The stock is considered modestly undervalued at $87.16 against a fair value of $90.37, supported …

Redtape Q1 Results 2027: Revenue Rises 4% YoY, PAT Increases 15% to ₹44 Cr

REDTAPE Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

REDTAPE: Revenue and profit rose year-over-year, with no material impact expected from tax searches

Is Medtronic (MDT) Becoming a Turnaround Story?

UBS upgraded Medtronic (NYSE:MDT) to a Buy from Neutral today, telling investors in a research note that a "turnaround" is underway at the company. The upgrade raises an important question for investors: Is Medtronic finally returning to sustainable growth after years of underperformance, or …

NewEdge Advisors LLC Trims Position in Medtronic PLC $MDT

NewEdge Advisors LLC has reduced its stake in Medtronic PLC (NYSE:MDT) by 12.4% during the first quarter, selling 25,953 shares and now holding 183,368 shares valued at $15.89 million. Despite this trim, several other institutional investors increased their positions in Medtronic. The article also …

Noticias de acciones de Medtronic PLC (MDT)

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

Medtronic and Intuitive Surgical, two leading medical device companies, have faced challenges this year but are poised for a rebound. Medtronic offers a strong dividend yield and diversified product portfolio, while Intuitive Surgical leads the robotic-assisted surgery market with its innovative da Vinci system. …

Medtronic PLC (MDT) Stock Analysis & Forecast

This article provides an analysis and forecast for Medtronic PLC (MDT) stock. It includes recent stock performance data, key financial metrics, and mentions two in-depth analyses published by TradingKey. These analyses cover broader market trends and Medtronic's strategy for capitalizing on the aging global …

Medtronic PLC $MDT Shares Purchased by Gradient Investments LLC

Gradient Investments LLC increased its stake in Medtronic PLC (NYSE:MDT) by 3.9% during the second quarter, bringing its total holdings to 496,513 shares valued at approximately $38.8 million. Other institutional investors also adjusted their positions in the medical technology company, with 82.06% of the …

Medtronic PLC (MDT) Aktienanalyse & Prognose

Czech National Bank Acquires 16,292 Shares of Medtronic PLC $MDT

The Czech National Bank increased its stake in Medtronic PLC (NYSE:MDT) by 4.7% in the second quarter, purchasing an additional 16,292 shares, bringing its total holdings to 365,443 shares valued at approximately $28.6 million. Medtronic recently exceeded quarterly earnings expectations, reporting $1.55 in adjusted …

Análise e Previsão das Ações da Medtronic PLC (MDT)

Medtronic (MDT) Wins Expanded CE Mark For Affera System In Ventricular Arrhythmias

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Medtronic (NYSE:MDT) receives expanded CE Mark indication for its Affera Mapping and Ablation System and Sphere-9 Catheter for ventricular arrhythmia treatment. The Sphere-9 catheter …